SPY334.19+5.46 1.66%
DIA275.90+4.20 1.55%
IXIC11,117.53+203.96 1.87%

Cancer Genetics Shareholders to Own 22% of the Combined Company Following Merger with StemoniX

Benzinga · 08/24/2020 12:17